Views & Analysis Could personalised medicine change treatment for migraine? The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific mutations making it to market.
News Stress not a significant factor in migraine attacks, study f... New findings from a digital study have challenged the belief that stress is a significant factor in triggering migraine attacks.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.